Literature DB >> 2642111

Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy.

A A Eddy1, D F Geary, J W Balfe, W F Clark, R Baumal.   

Abstract

Two children with prototypic hemolytic-uremic syndrome had prolonged acute dialysis-dependent renal failure (74 and 84 days) associated with a state of hyperproteinemia induced by extensive infusion of fresh frozen plasma (283 and 307 units). We believe that the hyperproteinemia prolonged the duration of renal failure. Following cessation of plasma therapy, the hyperproteinemic state reversed, the degree of proteinuria decreased and renal function quickly recovered. Although the pathophysiological mechanism requires further evaluation, we speculate that an alteration in the colloid oncotic pressure and/or aggravation of tubulointerstitial injury due to overload-proteinuria may have increased the duration of renal failure.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642111     DOI: 10.1007/bf00850219

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.

Authors:  S Chow; J Roscoe; D C Cattran
Journal:  Am J Kidney Dis       Date:  1986-05       Impact factor: 8.860

2.  Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology.

Authors:  C Loirat; E Sonsino; N Hinglais; J P Jais; P Landais; J Fermanian
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

3.  Hyperproteinemic proteinuria induced by plasma infusion.

Authors:  P N McLaine; M I Marks; T Baliah; K N Drummond
Journal:  Pediatr Res       Date:  1969-11       Impact factor: 3.756

4.  Renal hemodynamic, fluid volume, and arterial pressure changes during hyperproteinemia.

Authors:  R D Manning
Journal:  Am J Physiol       Date:  1987-03

5.  Haemolytic-uraemic syndrome with renal failure: the effect of plasmapheresis.

Authors:  L Camba; M M Al-Hilali; M M Shulji; M V Joyner; T G Feest
Journal:  Haematologica       Date:  1985 Jul-Aug       Impact factor: 9.941

6.  Treatment of postpartum hemolytic uremic syndrome with plasma exchange.

Authors:  C D Spencer; F M Crane; J R Kumar; B M Alving
Journal:  JAMA       Date:  1982-05-28       Impact factor: 56.272

7.  Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial.

Authors:  G Rizzoni; A Claris-Appiani; A Edefonti; P Facchin; F Franchini; R Gusmano; E Imbasciati; L Pavanello; F Perfumo; G Remuzzi
Journal:  J Pediatr       Date:  1988-02       Impact factor: 4.406

8.  Low molecular weight proteinuria exacerbates experimental ischemic renal injury.

Authors:  R A Zager; E J Teubner; S Adler
Journal:  Lab Invest       Date:  1987-02       Impact factor: 5.662

9.  Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

Authors:  G Remuzzi; R Misiani; D Marchesi; M Livio; G Mecca; G de Gaetano; M B Donati
Journal:  Lancet       Date:  1978-10-21       Impact factor: 79.321

10.  Proteinuria induced by transplantable rat pituitary tumor MtT SA5. Model for homologous protein-overload proteinuria.

Authors:  H Mori; H Yamashita; C Nakanishi; K Koizumi; S Makino; Y Kishimoto; Y Hayashi
Journal:  Lab Invest       Date:  1986-06       Impact factor: 5.662

  10 in total
  5 in total

Review 1.  Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes.

Authors:  B S Kaplan; T G Cleary; T G Obrig
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

2.  Plasma therapy for severe hemolytic-uremic syndrome in children in Atlantic Canada.

Authors:  M R Ogborn; J F Crocker; D R Barnard
Journal:  CMAJ       Date:  1990-12-15       Impact factor: 8.262

Review 3.  Haemolytic uraemic syndrome.

Authors:  W L Robson
Journal:  Paediatr Drugs       Date:  2000 Jul-Aug       Impact factor: 3.022

4.  Challenges in the management of infantile factor H associated hemolytic uremic syndrome.

Authors:  Guido Filler; Seetha Radhakrishnan; Lisa Strain; Andrew Hill; Greg Knoll; Timothy H Goodship
Journal:  Pediatr Nephrol       Date:  2004-06-16       Impact factor: 3.714

5.  Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age.

Authors:  C Renaud; P Niaudet; M F Gagnadoux; M Broyer; R Habib
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.